Login to Your Account

'Myriad' Patent Issues at Stake as High Court Conferences

By Marie Powers
Staff Writer

Thursday, November 29, 2012
At Friday's conference session, the Supreme Court will consider for the second time whether to grant cert to Association for Molecular Pathology v. Myriad Genetics Inc., a challenge to the Salt Lake City-based company's claims on the BRCA1 and BRCA2 genes used in diagnostics for breast and ovarian cancers.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription